Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in South Korea / NCT07629297
Recruiting Observational

A Korean Point Prevalence Study of Acute Rehabilitation for Kids in the PICU (PARK-PICU)

NCT07629297 · tracked via the Priya Life Science South Korea tracker
Sponsor
Samsung Medical Center
Phase
Observational
Started
2026-05-28
Last updated
2026-09-23

Condition(s) studied

Pediatric Intensive Care Units

Investigational drug(s) / intervention(s)

Acute Rehabilitation (Observed Practice)

Acute Rehabilitation (Observed Practice): This study does not assign any interventions. It observes routine clinical practices of acute rehabilitation provided to children in pediatric intensive care units as part of standard care.

Study summary

This study investigates the prevalence of acute rehabilitation practices among children in pediatric intensive care units (PICUs).

Eligibility

Sex
ALL
Min age
0 Days
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Children and adolescents aged 18 years or younger who have been admitted to the pediatric intensive care unit (PICU) for at least 72 hours as of 9:00 AM on the predefined study date at participating hospitals. Exclusion Criteria: * No exclusion criteria. All eligible patients meeting the inclusion criteria will be included to comprehensively assess the real-world prevalence of acute rehabilitation practices and associated barriers in pediatric intensive care units.

Primary outcome measure(s)

  • Proportion of Participants Who Received Acute Rehabilitation — At three seasonal point-prevalence assessments conducted approximately 6 months apart over an 18-month period
    Prevalence is defined as the proportion of eligible children in the pediatric intensive care unit who received at least one session of physical therapy or occupational therapy within the 24 hours preceding each study assessment point.

Trial sites (13)

FacilityCityRegionStatus
Kyungpook National University Chilgok Hospital Daegu Daegu Recruiting
Chungnam National University Hospital Daejeon Daejeon Recruiting
Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do Recruiting
Pusan National University Yangsan Hospital Yangsan Gyeongsangnam-do Recruiting
Inha University Hospital Incheon Incheon Recruiting
Jeju National University Hospital Jeju City Jeju-do Recruiting
Jeonbuk National University Hospital Jeonju Jeollabuk-do Recruiting
Chonnam National University Hwasun Hospital Hwasun Jeollanam-do Recruiting
Seoul National University Hospital Seoul Seoul Recruiting
Severance Hospital Seoul Seoul Recruiting
Asan Medical Center Seoul Seoul Recruiting
Samsung Medical Center Seoul Seoul Recruiting
Seoul St. Mary's Hospital Seoul Seoul Recruiting

More Samsung Medical Center trials in South Korea

IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute MI Recruiting
Genomic Profiling of Pancreatic Cystic Tumors Starting soon
Head and Neck Cancer Omics/Integrated Precision Medicine (HOPE) Recruiting
Korean Stroke Cohort for Functioning and Rehabilitation-II Active, not recruiting
Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07629297 on ClinicalTrials.gov ↗ ← All trials in South Korea